Team

Jeffrey C. Lightcap, Senior Managing Director, founded HealthCor Partners in 2008. Prior to joining HealthCor Partners, Mr. Lightcap was a Senior Managing Director at JLL Partners, a leading middle-market private equity fund, from 1997 to mid-2006. Prior to JLL Partners, Mr. Lightcap was a Managing Director at Merrill Lynch & Co., Inc. ("Merrill Lynch") in charge of leverage buyout coverage for Merrill Lynch's mergers and acquisitions group. Prior to joining Merrill Lynch, Mr. Lightcap was a Senior Vice President in the mergers and acquisitions group at Kidder, Peabody & Co. and briefly at Salomon Brothers.

Mr. Lightcap received a B.E. in Mechanical Engineering from the State University of New York in 1981 and an M.B.A. from the University of Chicago in 1985.

Mr. Lightcap serves on the board of directors of a number of companies, including CareView Communications, HeartFlow, KellBenx, Paige.AI and Surgalign Holdings.  Previously, Mr. Lightcap served on the board of directors of Corindus Vascular Robotics (acquired by Siemens Healthineers), Paradigm Spine (acquired by RTI Surgical), AccessClosure (acquired by Cardinal Health), Sadra Medical (acquired by Boston Scientific), Practice Partners in Healthcare (acquired by Surgical Care Affiliates, LLC), Iasis Healthcare Corporation, in addition to service on other private company boards.

Michael Y. Mashaal, M.D., Senior Managing Director, also a Founding Partner of HealthCor Partners, joined HealthCor Group in September 2005. Prior to joining the private equity team in 2007, Dr. Mashaal was a Senior Research Analyst focused on biotechnology for the HealthCor Group from 2005 to 2007. Previously, from 2000 to 2005, Dr. Mashaal served as a Research Analyst focused on healthcare and biotechnology for several large institutional investment firms.

Dr. Mashaal graduated from Emory University in 1994 with a B.A. in Biology. After receiving an M.D. at State University of New York at Stony Brook School of Medicine in 1998, Dr. Mashaal trained in general surgery at the University Hospital at Stony Brook from 1998 to 1999.

Dr. Mashaal currently serves on the board of directors of KellBenx and Orphion Therapeutics.  He also serves as a board observer of HeartFlow and Paige.AI. Previously, Dr. Mashaal served on the board of directors of Corindus Vascular Robotics (acquired by Siemens Healthineers), Paradigm Spine (acquired by RTI Surgical), Apatech (acquired by Baxter), Velcera (acquired by Perrigo) and ReShape LifeSciences. He also served as a board observer of Natera, in addition to service on other private company boards.

Elizabeth Lilley, VP of Finance and Administration, joined HealthCor Partners in 2007. Prior to joining the private equity team, Elizabeth was an Associate at HealthCor Management, LP from 2005 to 2007.

Ms. Lilley graduated from Union College in 2005 with a B.A. in Psychology.